Chemed executive receives 12,759 options, vesting over 3 years
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Chemed Corp (CHE) executive vice president Spencer S. Lee reported a stock option grant. On 10/21/2025, he received 12,759 stock options with an exercise price of $443.79 per share, expiring on 10/21/2030. The options vest in three equal annual installments beginning 10/21/2026. Following this grant, he beneficially owned 28,196 derivative securities, held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
LEE SPENCER S
Role
executive vice president
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy with tandem tax withholding) | 12,759 | $443.79 | $5.66M |
Holdings After Transaction:
Stock Option (right to buy with tandem tax withholding) — 28,196 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did CHE’s executive report on Form 4?
An option grant of 12,759 shares at an exercise price of $443.79 per share.
Who is the reporting person in CHE’s Form 4?
Executive vice president Spencer S. Lee.
When do the CHE options vest?
They vest in three equal annual installments starting 10/21/2026.
What is the expiration date of the CHE options?
The options expire on 10/21/2030.
How many derivative securities did the officer hold after the transaction?
He beneficially owned 28,196 derivative securities after the grant.
What is the issuer and ticker in this filing?
The issuer is Chemed Corp with ticker CHE.